Cargando…

Yeast as a Heterologous Model System to Uncover Type III Effector Function

Type III effectors (T3E) are key virulence proteins that are injected by bacterial pathogens inside the cells of their host to subvert cellular processes and contribute to disease. The budding yeast Saccharomyces cerevisiae represents an important heterologous system for the functional characterisat...

Descripción completa

Detalles Bibliográficos
Autores principales: Popa, Crina, Coll, Núria S., Valls, Marc, Sessa, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767418/
https://www.ncbi.nlm.nih.gov/pubmed/26914889
http://dx.doi.org/10.1371/journal.ppat.1005360
_version_ 1782417809374969856
author Popa, Crina
Coll, Núria S.
Valls, Marc
Sessa, Guido
author_facet Popa, Crina
Coll, Núria S.
Valls, Marc
Sessa, Guido
author_sort Popa, Crina
collection PubMed
description Type III effectors (T3E) are key virulence proteins that are injected by bacterial pathogens inside the cells of their host to subvert cellular processes and contribute to disease. The budding yeast Saccharomyces cerevisiae represents an important heterologous system for the functional characterisation of T3E proteins in a eukaryotic environment. Importantly, yeast contains eukaryotic processes with low redundancy and are devoid of immunity mechanisms that counteract T3Es and mask their function. Expression in yeast of effectors from both plant and animal pathogens that perturb conserved cellular processes often resulted in robust phenotypes that were exploited to elucidate effector functions, biochemical properties, and host targets. The genetic tractability of yeast and its amenability for high-throughput functional studies contributed to the success of this system that, in recent years, has been used to study over 100 effectors. Here, we provide a critical view on this body of work and describe advantages and limitations inherent to the use of yeast in T3E research. “Favourite” targets of T3Es in yeast are cytoskeleton components and small GTPases of the Rho family. We describe how mitogen-activated protein kinase (MAPK) signalling, vesicle trafficking, membrane structures, and programmed cell death are also often altered by T3Es in yeast and how this reflects their function in the natural host. We describe how effector structure–function studies and analysis of candidate targeted processes or pathways can be carried out in yeast. We critically analyse technologies that have been used in yeast to assign biochemical functions to T3Es, including transcriptomics and proteomics, as well as suppressor, gain-of-function, or synthetic lethality screens. We also describe how yeast can be used to select for molecules that block T3E function in search of new antibacterial drugs with medical applications. Finally, we provide our opinion on the limitations of S. cerevisiae as a model system and its most promising future applications.
format Online
Article
Text
id pubmed-4767418
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47674182016-03-09 Yeast as a Heterologous Model System to Uncover Type III Effector Function Popa, Crina Coll, Núria S. Valls, Marc Sessa, Guido PLoS Pathog Review Type III effectors (T3E) are key virulence proteins that are injected by bacterial pathogens inside the cells of their host to subvert cellular processes and contribute to disease. The budding yeast Saccharomyces cerevisiae represents an important heterologous system for the functional characterisation of T3E proteins in a eukaryotic environment. Importantly, yeast contains eukaryotic processes with low redundancy and are devoid of immunity mechanisms that counteract T3Es and mask their function. Expression in yeast of effectors from both plant and animal pathogens that perturb conserved cellular processes often resulted in robust phenotypes that were exploited to elucidate effector functions, biochemical properties, and host targets. The genetic tractability of yeast and its amenability for high-throughput functional studies contributed to the success of this system that, in recent years, has been used to study over 100 effectors. Here, we provide a critical view on this body of work and describe advantages and limitations inherent to the use of yeast in T3E research. “Favourite” targets of T3Es in yeast are cytoskeleton components and small GTPases of the Rho family. We describe how mitogen-activated protein kinase (MAPK) signalling, vesicle trafficking, membrane structures, and programmed cell death are also often altered by T3Es in yeast and how this reflects their function in the natural host. We describe how effector structure–function studies and analysis of candidate targeted processes or pathways can be carried out in yeast. We critically analyse technologies that have been used in yeast to assign biochemical functions to T3Es, including transcriptomics and proteomics, as well as suppressor, gain-of-function, or synthetic lethality screens. We also describe how yeast can be used to select for molecules that block T3E function in search of new antibacterial drugs with medical applications. Finally, we provide our opinion on the limitations of S. cerevisiae as a model system and its most promising future applications. Public Library of Science 2016-02-25 /pmc/articles/PMC4767418/ /pubmed/26914889 http://dx.doi.org/10.1371/journal.ppat.1005360 Text en © 2016 Popa et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Review
Popa, Crina
Coll, Núria S.
Valls, Marc
Sessa, Guido
Yeast as a Heterologous Model System to Uncover Type III Effector Function
title Yeast as a Heterologous Model System to Uncover Type III Effector Function
title_full Yeast as a Heterologous Model System to Uncover Type III Effector Function
title_fullStr Yeast as a Heterologous Model System to Uncover Type III Effector Function
title_full_unstemmed Yeast as a Heterologous Model System to Uncover Type III Effector Function
title_short Yeast as a Heterologous Model System to Uncover Type III Effector Function
title_sort yeast as a heterologous model system to uncover type iii effector function
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767418/
https://www.ncbi.nlm.nih.gov/pubmed/26914889
http://dx.doi.org/10.1371/journal.ppat.1005360
work_keys_str_mv AT popacrina yeastasaheterologousmodelsystemtouncovertypeiiieffectorfunction
AT collnurias yeastasaheterologousmodelsystemtouncovertypeiiieffectorfunction
AT vallsmarc yeastasaheterologousmodelsystemtouncovertypeiiieffectorfunction
AT sessaguido yeastasaheterologousmodelsystemtouncovertypeiiieffectorfunction